ARHGDIB Antikörper
-
- Target Alle ARHGDIB Antikörper anzeigen
- ARHGDIB (rho GDP Dissociation Inhibitor (GDI) beta (ARHGDIB))
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ARHGDIB Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Antigen affinity purification
- Immunogen
- Synthetic peptide of human ARHGDIB
- Isotyp
- IgG
- Top Product
- Discover our top product ARHGDIB Primärantikörper
-
-
- Applikationshinweise
- WB 1:500-1:2000, IHC 1:25-1:100, ELISA 1:5000-1:10000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- ARHGDIB (rho GDP Dissociation Inhibitor (GDI) beta (ARHGDIB))
- Andere Bezeichnung
- ARHGDIB (ARHGDIB Produkte)
- Hintergrund
- ARHGDIB,also known as RhoGDI2,is a conserved member of the RhoGDI family and plays an important role in cell migrations. It regulates the GDP/GTP exchange reaction of the Rho proteins by inhibiting the dissociation of GDP from them,and the subsequent binding of GTP to them. It is mainly in hematopoietic,endothelial,and epithelial cells. It has been linked to tumorigenesis and metastasis. RhoGDI2 expression is downregulated in several cancer types,such as bladder,lung and lymphoma,but is upregulated in prostate and gastric cancer.
- Molekulargewicht
-
Observed_MW: Refer to figures
Calculated_MW: 23 kDa
- UniProt
- P52566
- Pathways
- Caspase Kaskade in der Apoptose
-